Clovis Oncology (CLVS) Falls: Stock Goes Down 6.8%

Clovis Oncology, Inc. (CLVS) saw a big move last session, as the company’s shares fell by nearly 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for CLVS as the stock is now up around 24.2% in the past one-month time frame.

This slump shouldn’t be too much of a surprise to investors, as Clovis Oncology has seen 3 negative revisions in the past few weeks and its current year earnings consensus has moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

CLVS currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the pharmaceutical industry may consider better-ranked stocks like Cambrex Corporation. (CBM), China Biologic Products, Inc. (CBPO) and Gilead Sciences Inc. (GILD). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



CLOVIS ONCOLOGY INC (CLVS): Free Stock Analysis Report


Zacks Investment Research